Phase 1b clinical trial via Modality AI (2023)(vergegenomics.com)

https://www.vergegenomics.com/news-blog/verge-genomics-will-use-modalityai-in-its-als-phase-1b-clinical-trial-of-its-lead-drug-candidate-vrg50635